Bacillus subtilis and gas and bloating

What 3 graded rows on bacillus subtilis agree on for gas and bloating, and where they differ. Counted side by side, never averaged.

What the rows agree on

Each block and row is one graded row from the Bacillus subtilis page, with its PubMed record.

Your question

Supplement
Bacillus subtilis Choose another

Bacillus subtilis and gas and bloating

3 rows · 276 people

Mostly no difference: 2 of 3 rows, and most of the people. 1 found an improvement.

No difference
Improved
Each block is one evidence row, sized by how many people it enrolled, with its grade inside.
  • Grade C× 1
  • No effect× 2
Rows
3
Trials
3
People
276

Where they differ

From the rows

The best-graded row, grade C, is a randomized trial of 76 people (2022) and found an improvement. 2 rows are graded No effect, our grade for adequately powered trials that found no effect.

By our six checks (size, design, length, who was studied, year and grade), the two sides do not differ cleanly. The dose and how each outcome was measured are in the rows below.

The rows

1 improved · 2 no difference
  1. No effectIntestinal gas symptoms in functional bloating · No difference

    RCT · n 100 · 2025 · Adults with functional bloating (Rome IV)

    5 billion CFU a day · 8 weeks

    No difference from placebo in the global gas score or any dimension at 4 or 8 weeks; in women only, belching and flatulence eased.

    Row on the Bacillus subtilis page · PubMed 39929203 (opens PubMed)

  2. No effectBloating, abdominal discomfort and gas · No difference

    RCT · n 100 · 2021 · Healthy adults with bloating

    5 billion CFU a day · 4 weeks

    No difference from placebo in bloating intensity, bloating days, abdominal discomfort or gas; a male subgroup improved.

    Row on the Bacillus subtilis page · PubMed 31719214 (opens PubMed)

  3. Grade CBloating, burping and flatulence in healthy adults · Improved

    RCT · n 76 · 2022 · Healthy adults

    2 billion CFU a day · 6 weeks

    More people improved on the combined bloating, burping and flatulence score with BS50 than placebo (47.4% vs 22.2%; OR 3.2, p = .024); burping improved (44.7% vs 22.2%), bloating only trended (p = .071); other symptoms unchanged.

    Row on the Bacillus subtilis page · PubMed 36269141 (opens PubMed)

Educational only. Not medical advice. Some links earn us a commission: kymatahealth.com/affiliate-disclosure.